VYNE Therapeutics Inc.

The current price of VYNE is 2.30 USD — it has decreased by 4.17% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange VYNE Therapeutics Inc. stocks are traded under the ticker VYNE.

VYNE Therapeutics Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.

VYNE stock is 6.67% volatile and has beta coefficient of 1.46. Check out the list of the most volatile stocks — is VYNE Therapeutics Inc. there?

One year price forecast for VYNE Therapeutics Inc. has a max estimate of 6.00 USD and a min estimate of 5.00 USD.

VYNE earnings for the last quarter are −1.59 USD whereas the estimation was −0.76 USD which accounts for −109.21% surprise. Estimated earnings for the next quarter are −0.50 USD. See more details about VYNE Therapeutics Inc. earnings.

VYNE Therapeutics Inc. revenue for the last quarter amounts to ‪114.00 K‬ USD despite the estimated figure of ‪150.00 K‬ USD. In the next quarter revenue is expected to reach ‪150.00 K‬ USD.

Yes, you can track VYNE Therapeutics Inc. financials in yearly and quarterly reports right on TradingView.

VYNE net income for the last quarter is ‪−6.19 M‬ USD, while the quarter before that showed ‪−6.58 M‬ USD of net income which accounts for 6.01% change. Track more VYNE Therapeutics Inc. financial stats to get the full picture.

Today VYNE Therapeutics Inc. has the market capitalization of ‪32.43 M‬, it has decreased by 9.27% over the last week.

No, VYNE doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, VYNE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade VYNE Therapeutics Inc. stock right from TradingView charts — choose your broker and connect to your account.

VYNE reached its all-time high on Feb 6, 2018 with the price of 2869.92 USD, and its all-time low was 1.67 USD and was reached on Jan 31, 2024.
See other stocks reaching their highest and lowest prices.

As of Apr 19, 2024, the company has 10.00 employees. See our rating of the largest employees — is VYNE Therapeutics Inc. on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So VYNE Therapeutics Inc. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating VYNE Therapeutics Inc. stock shows the sell signal. See more of VYNE Therapeutics Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

We've gathered analysts' opinions on VYNE Therapeutics Inc. future price: according to them, VYNE price has a max estimate of 6.00 USD and a min estimate of 5.00 USD. Read a more detailed VYNE Therapeutics Inc. forecast: see what analysts think of VYNE Therapeutics Inc. and suggest that you do with its stocks.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. VYNE Therapeutics Inc. EBITDA is ‪−29.26 M‬ USD, and current EBITDA margin is ‪−6.90 K‬%. See more stats in VYNE Therapeutics Inc. financial statements.